The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sorafenib plus 5-azacytidine (AZA) in older untreated FLT3-ITD mutated AML.
 
Maro Ohanian
Travel, Accommodations, Expenses - Aptose Biosciences
 
Guillermo Garcia-Manero
No Relationships to Disclose
 
Mark J. Levis
No Relationships to Disclose
 
Elias Jabbour
Consulting or Advisory Role - Pfizer
Research Funding - Pfizer
 
Naval Guastad Daver
No Relationships to Disclose
 
Gautam Borthakur
No Relationships to Disclose
 
Tapan M. Kadia
No Relationships to Disclose
 
Mark Brandt
No Relationships to Disclose
 
Sherry Pierce
No Relationships to Disclose
 
Jan Andreas Burger
No Relationships to Disclose
 
Mary Ann Richie
No Relationships to Disclose
 
Keyur Patel
No Relationships to Disclose
 
Jorge E. Cortes
Consulting or Advisory Role - Amphivena Therapeutics; ARIAD; BiolineRx; Bristol-Myers Squibb; Janssen; Novartis; Pfizer
Research Funding - Ambit BioSciences (Inst); ARIAD (Inst); Arog (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celator (Inst); Celgene (Inst); Immunogen (Inst); Incyte (Inst); Novartis (Inst); Pfizer (Inst); Teva (Inst)
 
Hagop M. Kantarjian
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst)
 
Farhad Ravandi
No Relationships to Disclose